Research context
A mitochondria-targeting peptide studied in clinical and preclinical energy research.
Mitochondrial research
A mitochondria-targeting peptide studied in clinical and preclinical energy research.
A mitochondria-targeting peptide studied in clinical and preclinical energy research.
Evidence map
Evidence levels describe study design. They do not by themselves establish safety or effectiveness.
Therapeutic Approaches Involving Mitochondria in the Treatment of Acute Kidney Injury.
Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future.
Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).
FRDA Investigator Initiated Study (IIS) With Elamipretide
Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress.
Mitochondrial-targeted SS-31 peptide attenuates radiation-induced cardiomyocyte senescence.
Mitochondrial-Targeted SS-31 Attenuates the Doxorubicin-Induced Cardiomyoblast H9C2 Cell Senescence.
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening.
Cadmium-cardiolipin disruption of respirasome assembly and redox balance through mitochondrial membrane rigidification.
Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds.
Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).
Reduction of Elevated Proton Leak Rejuvenates Mitochondria in the Aged Cardiomyocyte.
Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after spinal cord injury
Elamipretide (SS-31) Improves Mitochondrial Dysfunction, Synaptic and Memory Impairment Induced by Lipopolysaccharide in Mice
Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress
<b>TIRZEPATIDE, ELAMIPRETIDE (SS-31), TESAMORELIN AND BREMELANOTIDE: MECHANISTIC FOUNDATIONS, CLINICAL EVIDENCE AND THERAPEUTIC APPLICATIONS IN METABOLIC, MITOCHONDRIAL AND NEUROENDOCRINE CONTEXTS</b>
Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages
Biophysical Approaches Toward Understanding the Molecular Mechanism of Action of the Mitochondrial Therapeutic SS-31 (Elamipretide)
Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice
Genome-Wide CRISPR Screen Reveals That Elamipretide (SS-31) Mediated PLSCR3 Activation Mitigates Mitochondrial Dysfunction During AKI
Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening
Molecular Mechanism of Action of Mitochondrial Therapeutic SS-31 (Elamipretide): Membrane Interactions and Effects on Surface Electrostatics
Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats
Elamipretide (SS-31) treatment attenuates age-associated post-translational modifications of heart proteins
Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages
Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats
Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice
Connected data hub
Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.
Zhang H, Alder N, Wang W, Szeto H, Marcinek D, Rabinovitch P · Innovation in Aging
Patai R, Patel K, Csik B, Gulej R, Nagaraja RY, Nagy D, Chandragiri SS, Shanmugarama S, Kordestan KV, Nagykaldi M, Ekambaram S, Ungvari A, Yabluchanskiy A, Tarantini S, Benyo Z, Csiszar A, Ungvari Z, Nyul-Toth A · GeroScience
Romanova N, Sule K, Issler T, Hebrok D, Persicke M, Thévenod F, Prenner EJ, Lee WK · Journal of lipid research
Xiao D, Cui X, Ali S, Li C, Wang B · Physiological research
Xie L, Wu J, Fan J, Krager KJ, Aykin-Burns N, Li S, Børsheim E, Qi X, Boerma M, Zhang H · Journal of radiation research
Fan J, Wu J, Yan S, Li S, Rabinovitch PS, Qi X, Zhang H · Biology
Mitchell W, Tamucci JD, Ng EL, Liu S, Birk AV, Szeto HH, May ER, Alexandrescu AT, Alder NN · eLife
Nashine S · Cells
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a major cause of cirrhosis, liver cancer, and cardiovascular disease. Early mitochondrial dysfunction drives lipid imbalance, inflammation, and fibrosis. Given the lack of approved pharmacological treatments, this study compares the mitochondria-targeted...
Qinghuan Yang, Yiyao Zhang, Pingping Liu, Zhiwen Yan, Changqing Li, Yinghong Tang, Qin Yang · Springer Science and Business Media LLC
Zengtao Song, Zhaoliang Ban, Haosen Zhao, Xifan Mei · Elsevier BV
Modern bioactive agents, including incretin receptor agonists, mitochondria-targeting peptides, growth hormone–releasing hormone analogues, and melanocortin receptor agonists, have substantially reshaped therapeutic strategies across metabolic disorders, HIV-associated lipodystrophy, hypoactive sexual desire disorder, and primary mitochondrial diseases. Tirzepatide has demonstrated...
Idiopathic pulmonary fibrosis (IPF) is a progressive fatal lung disease with a limited therapeutic strategy. Mitochondrial oxidative stress in macrophages is directly linked to IPF. Elamipretide(SS-31) is a mitochondrion-targeted peptide that has been shown to be safe and...
Josie A. Silvaroli, Bijay Bisunke, Ji Young Kim, Navjot Singh P. Pabla, Amandeep Bajwa · Ovid Technologies (Wolters Kluwer Health)
Nathan N. Alder, Wayne Mitchell, Emily Ng, Kevin Boyd, Jeffrey Tamucci, Eric May, Nicholas Eddy, Hazel Szeto · Elsevier BV
Background: It is widely accepted that mitochondria have a direct impact on neuronal function and survival. Oxidative stress caused by mitochondrial abnormalities play an important role in the pathophysiology of lipopolysaccharide (LPS)-induced memory impairment. Elamipretide (SS-31) is a...
Patel PS, Pabla NS, Bajwa A
Ciszewski P, Drelichowska A, Pikor D, Wiśniewska E, Azierski M
Nashine S
Roland Patai, Krish Patel, Boglárka Csík, Rafał Gulej, Raghavendra Yelahanka Nagaraja, Dorina Nagy et al. · GeroScience · 15 citations
Yunjuan Nie, Jiao Li, Xiaorun Zhai, Zhixu Wang, Junpeng Wang, Yaxian Wu et al. · Antioxidants · 23 citations
Jeremy D. Whitson, Miguel Martín‐Pérez, Tong Zhang, Matthew J. Gaffrey, Gennifer E. Merrihew, Eric L. Huang et al. · GeroScience · 34 citations
Yang Liu, Huiqun Fu, Yan Wu, Binbin Nie, Fangyan Liu, Tianlong Wang et al. · Frontiers in Aging Neuroscience · 30 citations
Weixing Zhao, Zhipeng Xu, Jiangbei Cao, Qiang Fu, Yishuang Wu, Xiaoying Zhang et al. · Journal of Neuroinflammation · 212 citations
Matthew D. Campbell, Jicheng Duan, Ashton T. Samuelson, Matthew J. Gaffrey, Gennifer E. Merrihew, Jarrett D. Egertson et al. · Free Radical Biology and Medicine · 144 citations
Jing Wu, Shuangying Hao, Xiaoru Sun, Hui Zhang, Huihui Li, Hongting Zhao et al. · Frontiers in Cellular Neuroscience · 44 citations
To evaluate the safety, tolerability, and activity of Elamipretide in treating vision loss in Friedreich Ataxia (FRDA).
Wayne A. Mitchell, Emily A. Ng, Jeffrey D. Tamucci, Kevin J. Boyd, Murugappan Sathappa, Adrian Coscia et al. · bioRxiv (Cold Spring Harbor Laboratory) · 7 citations
Live discovery
Live results from PubMed, ClinicalTrials.gov and UniProt. These may not yet have been reviewed or stored in the Data Hub.
Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.